1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of cancer demands cancer biological therapy
5.1.1.2. Rising awareness on cancer coupled with increased healthcare expenditure
5.1.1.3. Increasing elderly population and risk of cancer globally
5.1.2. Restraints
5.1.2.1. Unaffordability due to capital intensive treatment
5.1.3. Opportunities
5.1.3.1. Ongoing technological advancements in cancer biologics
5.1.3.2. Rising research and development activities coupled with favorable government policies
5.1.4. Challenges
5.1.4.1. Probable effects of anti-cancer drug therapy
5.2. Cumulative Impact of COVID-19

6. Cancer Biological Therapy Market, by Product
6.1. Introduction
6.2. Cancer Growth Blockers
6.3. Monoclonal Antibodies
6.4. Vaccines

7. Cancer Biological Therapy Market, by Distribution Channel
7.1. Introduction
7.2. Hospital
7.3. Retail & Mail Order Pharmacies

8. Americas Cancer Biological Therapy Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Cancer Biological Therapy Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Cancer Biological Therapy Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. AbbVie, Inc
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Amgen Inc.
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Astellas Pharma Inc.
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. AstraZeneca PLC
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Bausch Health Companies Inc.
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Bayer AG
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Bristol-Myers Squibb
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Celgene Corporation
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Eisai Co., Ltd.
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Eli Lilly and Company
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. EnGeneIC Ltd
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. F. Hoffmann-La Roche AG
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. GlaxoSmithKline PLC
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Hikma Pharmaceuticals PLC
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Incyte Corp
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. Johnson & Johnson Services, Inc,
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. Merck & Co., Inc.
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Novartis International AG
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Otsuka Pharmaceutical Co., Ltd
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Pfizer, Inc
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. Sanofi SA
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services
12.22. Spectrum Pharmaceuticals, Inc.
12.22.1. Business Overview
12.22.2. Key Executives
12.22.3. Product & Services
12.23. Takeda Pharmaceutical Company Limited
12.23.1. Business Overview
12.23.2. Key Executives
12.23.3. Product & Services
12.24. Teva Pharmaceutical Industries Ltd
12.24.1. Business Overview
12.24.2. Key Executives
12.24.3. Product & Services

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL CANCER BIOLOGICAL THERAPY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 4. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. GLOBAL CANCER BIOLOGICAL THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL CANCER BIOLOGICAL THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL CANCER BIOLOGICAL THERAPY MARKET DYNAMICS
FIGURE 11. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 12. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL CANCER BIOLOGICAL THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2027
FIGURE 14. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY CANCER GROWTH BLOCKERS, 2018-2027 (USD BILLION)
FIGURE 15. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2027 (USD BILLION)
FIGURE 16. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY VACCINES, 2018-2027 (USD BILLION)
FIGURE 17. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 18. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL CANCER BIOLOGICAL THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY DISTRIBUTION CHANNEL, 2027
FIGURE 20. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY HOSPITAL, 2018-2027 (USD BILLION)
FIGURE 21. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY RETAIL & MAIL ORDER PHARMACIES, 2018-2027 (USD BILLION)
FIGURE 22. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 23. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 24. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 25. AMERICAS CANCER BIOLOGICAL THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 26. ARGENTINA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 27. BRAZIL CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 28. CANADA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 29. MEXICO CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 30. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 31. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 32. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 33. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 34. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 35. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 36. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 37. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 38. AUSTRALIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 39. CHINA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 40. INDIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 41. INDONESIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 42. JAPAN CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 43. MALAYSIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 44. PHILIPPINES CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 45. SINGAPORE CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 46. SOUTH KOREA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 47. TAIWAN CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 48. THAILAND CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 49. VIETNAM CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 50. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 54. DENMARK CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 55. EGYPT CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 56. FINLAND CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 57. FRANCE CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 58. GERMANY CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 59. ISRAEL CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 60. ITALY CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 61. NETHERLANDS CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 62. NIGERIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 63. NORWAY CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. POLAND CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 65. QATAR CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 66. RUSSIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 67. SAUDI ARABIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 68. SOUTH AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 69. SPAIN CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 70. SWEDEN CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 71. SWITZERLAND CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 72. TURKEY CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 73. UNITED ARAB EMIRATES CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 74. UNITED KINGDOM CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 75. GLOBAL CANCER BIOLOGICAL THERAPY MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 76. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 77. GLOBAL CANCER BIOLOGICAL THERAPY MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021

List of Tables

TABLE 1. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY CANCER GROWTH BLOCKERS, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY CANCER GROWTH BLOCKERS, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY CANCER GROWTH BLOCKERS, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY VACCINES, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY VACCINES, BY REGION, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY VACCINES, BY REGION, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 17. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY HOSPITAL, 2018-2027 (USD BILLION)
TABLE 18. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 19. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 20. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY RETAIL & MAIL ORDER PHARMACIES, 2018-2027 (USD BILLION)
TABLE 21. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY RETAIL & MAIL ORDER PHARMACIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 22. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY RETAIL & MAIL ORDER PHARMACIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 23. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 24. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 25. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 26. AMERICAS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 27. ARGENTINA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 28. ARGENTINA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 29. ARGENTINA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 30. BRAZIL CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 31. BRAZIL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 32. BRAZIL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 33. CANADA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 34. CANADA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 35. CANADA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 36. MEXICO CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 37. MEXICO CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 38. MEXICO CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 39. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 40. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY STATE, 2018-2027 (USD BILLION)
TABLE 41. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 42. UNITED STATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 43. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 44. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 45. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 46. ASIA-PACIFIC CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 47. AUSTRALIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 48. AUSTRALIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 49. AUSTRALIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 50. CHINA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 51. CHINA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 52. CHINA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 53. INDIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 54. INDIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 55. INDIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 56. INDONESIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 57. INDONESIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 58. INDONESIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 59. JAPAN CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 60. JAPAN CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 61. JAPAN CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 62. MALAYSIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 63. MALAYSIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 64. MALAYSIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 65. PHILIPPINES CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 66. PHILIPPINES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 67. PHILIPPINES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 68. SINGAPORE CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 69. SINGAPORE CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 70. SINGAPORE CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 71. SOUTH KOREA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 72. SOUTH KOREA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 73. SOUTH KOREA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 74. TAIWAN CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 75. TAIWAN CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 76. TAIWAN CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 77. THAILAND CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 78. THAILAND CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 79. THAILAND CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 80. VIETNAM CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 81. VIETNAM CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 82. VIETNAM CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 87. DENMARK CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 88. DENMARK CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 89. DENMARK CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 90. EGYPT CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 91. EGYPT CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 92. EGYPT CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 93. FINLAND CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 94. FINLAND CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 95. FINLAND CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 96. FRANCE CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 97. FRANCE CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 98. FRANCE CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 99. GERMANY CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 100. GERMANY CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 101. GERMANY CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 102. ISRAEL CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 103. ISRAEL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 104. ISRAEL CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 105. ITALY CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 106. ITALY CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 107. ITALY CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 108. NETHERLANDS CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 109. NETHERLANDS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 110. NETHERLANDS CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 111. NIGERIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 112. NIGERIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 113. NIGERIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 114. NORWAY CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 115. NORWAY CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 116. NORWAY CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 117. POLAND CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 118. POLAND CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 119. POLAND CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 120. QATAR CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 121. QATAR CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 122. QATAR CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 123. RUSSIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 124. RUSSIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 125. RUSSIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 126. SAUDI ARABIA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 127. SAUDI ARABIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 128. SAUDI ARABIA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 129. SOUTH AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 130. SOUTH AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 131. SOUTH AFRICA CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 132. SPAIN CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 133. SPAIN CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 134. SPAIN CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 135. SWEDEN CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 136. SWEDEN CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 137. SWEDEN CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 138. SWITZERLAND CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 139. SWITZERLAND CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 140. SWITZERLAND CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 141. TURKEY CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 142. TURKEY CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 143. TURKEY CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 144. UNITED ARAB EMIRATES CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 145. UNITED ARAB EMIRATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 146. UNITED ARAB EMIRATES CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 147. UNITED KINGDOM CANCER BIOLOGICAL THERAPY MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 148. UNITED KINGDOM CANCER BIOLOGICAL THERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 149. UNITED KINGDOM CANCER BIOLOGICAL THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 150. GLOBAL CANCER BIOLOGICAL THERAPY MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 151. GLOBAL CANCER BIOLOGICAL THERAPY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 152. GLOBAL CANCER BIOLOGICAL THERAPY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 153. GLOBAL CANCER BIOLOGICAL THERAPY MARKET RANKING, BY KEY PLAYER, 2021
TABLE 154. GLOBAL CANCER BIOLOGICAL THERAPY MARKET SHARE, BY KEY PLAYER, 2021
TABLE 155. GLOBAL CANCER BIOLOGICAL THERAPY MARKET MERGER & ACQUISITION
TABLE 156. GLOBAL CANCER BIOLOGICAL THERAPY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 157. GLOBAL CANCER BIOLOGICAL THERAPY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 158. GLOBAL CANCER BIOLOGICAL THERAPY MARKET INVESTMENT & FUNDING
TABLE 159. GLOBAL CANCER BIOLOGICAL THERAPY MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 160. GLOBAL CANCER BIOLOGICAL THERAPY MARKET: LICENSE & PRICING

Companies Mentioned

AbbVie, Inc
Amgen Inc.
Astellas Pharma Inc.
AstraZeneca PLC
Bausch Health Companies Inc.
Bayer AG
Bristol-Myers Squibb
Celgene Corporation
Eisai Co., Ltd.
Eli Lilly and Company
EnGeneIC Ltd
F. Hoffmann-La Roche AG
GlaxoSmithKline PLC
Hikma Pharmaceuticals PLC
Incyte Corp
Johnson & Johnson Services, Inc,
Merck & Co., Inc.
Novartis International AG
Otsuka Pharmaceutical Co., Ltd
Pfizer, Inc
Sanofi SA
Spectrum Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Ltd